EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A companion to the preclinical common data elements for rigor, reproducibility and transparency in basic and translational epilepsy research. A report of the TASK3 ‐ WG1A : Pharmacology Working Group of the ILAE / AES Joint Translational Task Force

Brian D Klein iD, Lauren Harte-Hargrove iD, Wenzhu Mowrey, Aristea S Galanopoulou iD, Cameron S Metcalf iD, Lisa Coles, Patrick A Forcelli iD, Anna-Maria Katsarou iD, Rudiger Koehling iD, Karine Leclercq iD, Heidrun Potschka iD, TASK3‐WG1A working group

Epilepsia Open · 2025

DOI: 10.1002/epi4.70053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2025. Verfasst von Brian D Klein und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Translational Research, Biomedical, Epilepsy, Research Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rigorous and transparent procedures in preclinical epilepsy research studies are important to permit assessing the reproducibility of their findings and derisk their translation into the clinic. The General Pharmacology Working Group of the ILAE/AES Task Force (TASK3‐WG1A) developed common data elements (CDEs) addressing rigor and transparency and organized the CDEs into a case report form (CRF) to provide guidance on study planning, conduct, analysis, and reporting. CDEs specifying the type of study, use of inclusion–exclusion criteria, quantitative methods, randomization, blinding, and masking were developed and defined. This companion paper provides additional information and interpretation on the use of the rigor and transparency CDEs to assist preclinical investigators. Adoption of these CDEs and CRF will enhance data quality and transparent reporting to improve the reuse of preclinical data sets and the successful translation of preclinical epilepsy research. The materials provided in the form of CDEs, CRF, and this companion paper can be used in the research community for training purposes and to promote more rigorous conduct and transparent reporting of basic and translational epilepsy research. Plain Language Summary The purpose of the Common Data Elements described in this companion paper is to improve the rigor, reproducibility, and transparency of basic and translational epilepsy research studies. Enhancing these important elements of preclinical epilepsy research will facilitate data sharing and comparisons between research laboratories and potentially the reliability of translating preclinical research findings to clinical studies that reduce the burden of disease for individuals with epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Translational Research, BiomedicalEpilepsyResearch DesignReproducibility of ResultsHumansAnimalsAdvisory CommitteesDrug Evaluation, Preclinical

Stichwörter der Autor:innen

common data elementspreclinicalreproducibilityrigortransparency

Autor:innen und Institutionen

  • National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • CURE Epilepsy, Chicago, Illinois, USA.
  • Division of Biostatistics, Department of Epidemiology and Population Health Albert Einstein College of Medicine, Bronx, New York, USA.
  • Saul R Korey Department of Neurology, Isabelle Rapin Division of Child Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Albert Einstein College of Medicine, Bronx, New Yor…
  • College of Pharmacy, Department of Pharmacology and Toxicology, The University of Utah, Salt Lake City, Utah, USA.
  • Department of Experimental and Clinical Pharmacology, The University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.

ORCID-Profile: Brian D Klein, Lauren Harte-Hargrove, Aristea S Galanopoulou, Cameron S Metcalf, Patrick A Forcelli, Anna-Maria Katsarou, Rudiger Koehling, Karine Leclercq, Heidrun Potschka

Förderung

  • NINDS NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Klein, B. D., Harte-Hargrove, L., Mowrey, W., Galanopoulou, A. S., Metcalf, C. S., Coles, L., Forcelli, P. A., Katsarou, A. M., Koehling, R., Leclercq, K., Potschka, H., & TASK3‐WG1A working group (2025). A companion to the preclinical common data elements for rigor, reproducibility and transparency in basic and translational epilepsy research. A report of the TASK3 ‐ WG1A : Pharmacology Working Group of the ILAE / AES Joint Translational Task Force. Epilepsia Open. https://doi.org/10.1002/epi4.70053

Vancouver

Klein BD, Harte-Hargrove L, Mowrey W, Galanopoulou AS, Metcalf CS, Coles L, et al. A companion to the preclinical common data elements for rigor, reproducibility and transparency in basic and translational epilepsy research. A report of the TASK3 ‐ WG1A : Pharmacology Working Group of the ILAE / AES Joint Translational Task Force. Epilepsia Open. 2025. doi:10.1002/epi4.70053

BibTeX
@article{Klein2025,
  author = {Klein, Brian D and Harte-Hargrove, Lauren and Mowrey, Wenzhu and Galanopoulou, Aristea S and Metcalf, Cameron S and Coles, Lisa and Forcelli, Patrick A and Katsarou, Anna-Maria and Koehling, Rudiger and Leclercq, Karine and Potschka, Heidrun and TASK3‐WG1A working group, TASK3‐WG1A working group},
  title = {A companion to the preclinical common data elements for rigor, reproducibility and transparency in basic and translational epilepsy research. A report of the TASK3 ‐ WG1A : Pharmacology Working Group of the ILAE / AES Joint Translational Task Force},
  journal = {Epilepsia Open},
  year = {2025},
  doi = {10.1002/epi4.70053}
}
Kostenlos starten →